Home FDA approves once-monthly Abilify for schizophrenia
 

Keywords :   


FDA approves once-monthly Abilify for schizophrenia

2013-03-01 04:10:30| Biotech - Topix.net

U.S. regulators on Thursday approved a once-monthly injectable form of Abilify, the blockbuster treatment for schizophrenia, which will be sold by Japanese drugmaker Otsuka and Danish drug group Lundbeck .

Tags: fda approves schizophrenia fda approves

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
24.06Apple in breach of law on App Store, says EU
24.06Atlantic Tropical Weather Outlook
24.06Eastern North Pacific Tropical Weather Outlook
24.06Parties ignoring 'painful' tax and spending choices, says think tank
24.06Atlantic Tropical Weather Outlook
24.06Eastern North Pacific Tropical Weather Outlook
24.06Criminal charges recommended against Boeing - reports
24.06Grounded flights rearranged after airport chaos
More »